Comparison of prostate‐specific membrane antigen ligands in clinical translation research for diagnosis of prostate cancer S Sengupta, M Asha Krishnan, S Chattopadhyay, V Chelvam Cancer Reports 2 (4), e1169, 2019 | 27 | 2019 |
Antibody-drug conjugates: The paradigm shifts in the targeted cancer therapy D Aggarwal, J Yang, MA Salam, S Sengupta, MY Al-Amin, S Mustafa, ... Frontiers in Immunology 14, 1203073, 2023 | 16 | 2023 |
Novel solid-phase strategy for the synthesis of ligand-targeted fluorescent-labelled chelating peptide conjugates as a theranostic tool for cancer S Sengupta, MA Krishnan, P Dudhe, RB Reddy, B Giri, S Chattopadhyay, ... Beilstein journal of organic chemistry 14 (1), 2665-2679, 2018 | 11 | 2018 |
Efficient “turn-on” nanosensor by dual emission-quenching mechanism of functionalized Se doped ZnO nanorods for mercury (II) detection AVRK Rao, RB Reddy, S Sengupta, V Chelvam Applied Nanoscience 8, 1973-1987, 2018 | 10 | 2018 |
First report on 3D-QSAR and molecular dynamics based docking studies of GCPII inhibitors for targeted drug delivery applications A Pandit, S Sengupta, MA Krishnan, RB Reddy, R Sharma, C Venkatesh Journal of Molecular Structure 1159, 179-192, 2018 | 9 | 2018 |
Tyrosine-based asymmetric urea ligand for prostate carcinoma: Tuning biological efficacy through in silico studies S Sengupta, MA Krishnan, A Pandit, P Dudhe, R Sharma, V Chelvam Bioorganic chemistry 91, 103154, 2019 | 8 | 2019 |
Structure activity relationships (SAR) study to design and synthesize new tubulin inhibitors with enhanced anti-tubulin activity: In silico and in vitro analysis A Pandit, K Yadav, RB Reddy, S Sengupta, R Sharma, V Chelvam Journal of Molecular Structure 1223, 129204, 2021 | 7 | 2021 |
Synthesis of tubuphenylalanine and epi-tubuphenylalanine via regioselective aziridine ring opening with carbon nucleophiles followed by hydroboration-oxidation of 1, 1 … RB Reddy, P Dudhe, P Chauhan, S Sengupta, V Chelvam Tetrahedron 74 (48), 6946-6953, 2018 | 5 | 2018 |
Preparation of Ligand‐Targeted Drug Conjugates for Cancer Therapy and Their Evaluation In Vitro MA Krishnan, S Sengupta, V Chelvam Current protocols in chemical biology 10 (4), e50, 2018 | 3 | 2018 |
Recent Advances in the Synthesis of Diarylheptanoids S Kasireddy, S Yarlagadda, S Sengupta Chemistry–An Asian Journal, e202400380, 2024 | | 2024 |
SMALL MOLECULE INHIBITORS FOR EARLY DIAGNOSIS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN CANCERS AND NEURODEGENERATIVE DISEASES C Venkatesh, S Sengupta, MA Krishnan, A Pandit IN Patent App. 201,821,044,594, 2020 | | 2020 |
Small molecule inhibitors for early diagnosis of prostate specific membrane antigen cancers and neurodegenerative diseases V Chelvam, S Sengupta, MA Krishnan, A Pandit US Patent US20200164075A1, 2020 | | 2020 |
Design, synthesis and biological evaluation of novel small molecule inhibitors for early diagnosis and therapy of diseased states S Sengupta Department of Chemistry, IIT Indore, 2019 | | 2019 |